罗氟司特在哪里买比较靠谱

Introduction: Roflumilast is a prescription drug used to treat chronic obstructive pulmonary disease (COPD). When purchasing, you need to choose formal channels to ensure the quality of the drug. Prices and purchase methods vary in different regions. Patients can obtain it through hospitals, regular pharmacies or authorized e-commerce platforms. Understanding the drug's availability and price information can help patients make more reasonable purchasing decisions.

Where to buy roflumilast more reliably

Priority should be given to regular medical institutions or authorized channels when purchasing, and avoid purchasing from unknown sources to avoid affecting the treatment effect or causing safety hazards.

Purchase in hospital pharmacies

Patients can purchase roflumilast with a prescription at hospitals with respiratory diagnosis and treatment qualifications. The sources of drugs in hospital pharmacies are reliable, and pharmacists can provide professional medication guidance.

Regular chain pharmacies

Large-scale chain pharmacies usually cooperate with regular drug suppliers and can provide guarantee of authenticity. When purchasing, you should present a doctor's prescription and check the approval number and production information on the drug packaging.

Although the price may be slightly higher if you choose formal purchase channels, you can ensure the quality and safety of medicines to the greatest extent and avoid purchasing counterfeit or expired medicines.

Roflumilast’s marketing status

Roflumilast has been approved for marketing in many countries and regions around the world. The launch time and indications may be slightly different in different regions.

Approval status in major countries and regions

The drug was approved in the European Union in 2010 and by the US FDA in 2011. It is currently sold in Germany, the United Kingdom, Hong Kong and other places, and has rich experience in clinical application.

Market situation in mainland China

Roflumilast has been approved for marketing in Hong Kong, China, and can be obtained by patients at medical institutions with relevant qualifications. However, it has not yet been launched in mainland China. The ingredients and efficacy of the domestic version are consistent with the imported version.

Understanding the marketing status of drugs can help determine the reliability of the drug source, and give priority to versions that have been officially approved locally.

The price of roflumilast

The price of roflumilast varies depending on the manufacturer, specification and sales region. Patients can choose a suitable purchase plan according to their own circumstances.

British AstraZeneca German version

The German version of roflumilast is produced by British AstraZeneca. The reference price of 500μg*30 tablets is about US$233, and the price of 90 tablets is about US$391. This version is mainly for the European market.

British AstraZeneca Hong Kong version

The reference price of 500μg*30 tablets produced by the same manufacturer in the Hong Kong market is about US$134. The price is relatively more advantageous and suitable for patients who need long-term medication.

Price differences are affected by many factors, including tariffs, transportation costs and local pharmaceutical policies. Patients should choose appropriate drug specifications and purchase channels according to the treatment plan under the guidance of a doctor.